| Literature DB >> 26816916 |
Anupama Muraleedharan1, Dhanya Sasidharan Palappallil2, Reneega Gangadhar3, Soumitra Das4.
Abstract
Sodium valproate induced hyperammonaemic delirium with normal liver function tests is a relatively uncommon adverse effect. It may be mistaken for psychosis or worsening of mania leading to wrong diagnosis and improper management. Plasma ammonia levels should be monitored in all patients developing altered mental status after receiving valproate therapy. This is a case series of hyperammonaemic delirium due to valproate reported to the Department of Pharmacology from Department of Psychiatry over a period of one year.Entities:
Keywords: Plasma ammonia; Valproate therapy
Year: 2015 PMID: 26816916 PMCID: PMC4717698 DOI: 10.7860/JCDR/2015/15562.6883
Source DB: PubMed Journal: J Clin Diagn Res ISSN: 0973-709X